Success Story Details
Driving American markets
A high-level Repurposing & Reformulation pharmaceutical company required a CFO to put their only recently publicly listed company on the American map.
A recently publicly listed pharmaceutical company was in dire need of a CFO to launch their 505B2 product on the American market. The unique company specialised in reformulation and repurposing of existing drugs; however, their focus had previously been on clinical research.
In their strive for success, a launch on the American market proved to be essential. The Chief Financial Officer, a key figure in the process to stock exchange, had to guide the company throughout.
The HR One Team was put in place to assure a professional and favourable outcome. When the company later desired a VP Clinical Affairs and a VP Regulatory Affairs, they returned for the same services.